Lacosamide in Neonatal Status Epilepticus

Phase 3UnknownNCT05291455

Sherief Abd-Elsalam60 enrolled

Overview

Lacosamide in neonatal status epilepticus

The study will assess the efficacy of Lacosamide in neonatal status epilepticus

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

QUADRUPLE

Enrollment

lacosamide will be given

phenobarbital will be given

Sex: ALLMax age: 28 Days

Medical Language ↔ Plain English

Inclusion Criteria: * neonates with status epilepticus Exclusion Criteria: * congenital anomalies or organ dysfunction

Kafrelsheikh University

Tanta, Kafrelsheikh, Egypt

RECRUITING

number of children with cessation or improved duration of status epilepticus

the number of children with cessation or improved duration of status epilepticus

Time frame: 1 year

abeer salamah, lecturer

CONTACT

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.